magnolol has been researched along with Innate Inflammatory Response in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.35) | 18.2507 |
| 2000's | 2 (8.70) | 29.6817 |
| 2010's | 13 (56.52) | 24.3611 |
| 2020's | 7 (30.43) | 2.80 |
| Authors | Studies |
|---|---|
| Edwards, BS; Graves, SW; Saunders, MJ; Sklar, LA; Zhu, J | 1 |
| Borymska, W; Kaczmarczyk-Sedlak, I; Szałabska-Rąpała, K | 1 |
| Gu, M; Guo, W; Huang, L; Liu, Y; Sun, H; Wang, N; Wu, Y; Xu, L; Yang, Y | 1 |
| Kim, MS; Kwon, KC; Park, SW; Shin, YW; Song, YS; Won, JG | 1 |
| Fu, Y; Hölscher, C; Jiang, Y; Wang, H; Xie, Z; Xu, J; Yang, Q; Zeng, H; Zhang, Z; Zhao, J | 1 |
| Chiu, KC; Hsia, SM; Jhuang, HS; Lan, WC; Li, PJ; Shen, YW; Shieh, TM; Shih, YH; Wang, TH; Yuan-Chien Chen, M | 1 |
| Fortunato, CRM; Gomes, KS; Grecco, SS; Lago, JHG; Oliveira, MA; Olivo, CR; Ponci, V; Prado, CM; Santana, FPR; Silva, RC; Tavares-de-Lima, W; Tibério, IFLC | 1 |
| Chen, SH; Hsieh, PL; Liao, YW; Liu, CM; Yu, CC; Yu, CH | 1 |
| Huang, YH; Jiang, YL; Kou, DQ; Qin, JH | 1 |
| Cao, H; Feng, Y; Li, W; Liao, S; Wu, X; Xiao, X; Zhong, W; Zhu, J | 1 |
| Cao, Y; Gu, C; He, Y; Li, S; Li, Y; Liu, J; Lu, X; Shen, P; Zhang, N; Zhang, Z; Zhu, K | 1 |
| Chen, H; Fu, W; Huang, J; Liu, X; Rui, W; Wei, Y; Yang, Y; You, S | 1 |
| Hu, Z; Jiang, Z; Yang, B; Zhou, F | 1 |
| Fang, C; Gao, L; Luo, J; Xu, Y; Zhang, M; Zhou, C | 1 |
| Cha, BY; Choi, MS; Jung, UJ; Kim, SR; Kim, YJ; Park, YB; Woo, JT | 1 |
| Dejie, L; Naisheng, Z; Tiancheng, W; Wei, W; Xiaojing, S; Yongguo, C; Zhengtao, Y | 1 |
| Coppola, M; Mondola, R | 1 |
| Li, J; Li, JY; Ren, HY; Su, H; Tang, WF; Wu, FS; Zhang, YM; Zhao, XL | 1 |
| Chan, MH; Chen, HH; Ko, CH; Lin, YC; Lin, YR | 1 |
| Ho, JH; Hong, CY | 1 |
| Cao, Y; Feng, X; Fu, Y; Li, F; Liang, D; Liu, B; Liu, Z; Yang, Z; Zhang, N; Zhang, X | 1 |
| Chan, MH; Chen, HH; Ko, CH; Lin, YR | 1 |
| Chen, CC; Kuo, JS; Raung, SL; Teng, CM; Wang, JP | 1 |
1 review(s) available for magnolol and Innate Inflammatory Response
| Article | Year |
|---|---|
Effectiveness of Magnolol, a Lignan from Magnolia Bark, in Diabetes, Its Complications and Comorbidities-A Review.
Topics: Animals; Biphenyl Compounds; Blood Glucose; Diabetes Complications; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Eye Diseases; Homeostasis; Humans; Hypoglycemic Agents; Inflammation; Lignans; Lipid Metabolism; Magnolia; Mice; Oxidative Stress; Plant Bark; Polyphenols; Treatment Outcome | 2021 |
22 other study(ies) available for magnolol and Innate Inflammatory Response
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; High-Throughput Screening Assays; Humans; Inflammation; Kinetics; Microspheres; Peptide Hydrolases; Peptides; Reproducibility of Results; Temperature | 2010 |
Magnolol limits NFκB-dependent inflammation by targeting PPARγ relieving retinal ischemia/reperfusion injury.
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Eosine Yellowish-(YS); Glaucoma; Hematoxylin; Inflammation; Ischemia; Mice; NF-kappa B; NF-KappaB Inhibitor alpha; PPAR gamma; Reperfusion Injury; Retina | 2022 |
Anti-acne activity of carnitine salicylate and magnolol through the regulation of exfoliation, lipogenesis, bacterial growth and inflammation.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Carnitine; Humans; Inflammation; Lignans; Lipogenesis; Salicylic Acid | 2023 |
Magnolol alleviates Alzheimer's disease-like pathology in transgenic C. elegans by promoting microglia phagocytosis and the degradation of beta-amyloid through activation of PPAR-γ.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Apolipoproteins E; Biphenyl Compounds; Caenorhabditis elegans; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Inflammation; Lignans; Microglia; NF-kappa B; Phagocytosis; PPAR gamma | 2020 |
In vitro antimicrobial and antipro-inflammation potential of honokiol and magnolol against oral pathogens and macrophages.
Topics: Animals; Anti-Bacterial Agents; Biphenyl Compounds; Humans; Inflammation; Lignans; Macrophages | 2021 |
Biseugenol Exhibited Anti-Inflammatory and Anti-Asthmatic Effects in an Asthma Mouse Model of Mixed-Granulocytic Asthma.
Topics: Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Biological Availability; Biphenyl Compounds; Computer Simulation; Disease Models, Animal; Granulocytes; Inflammation; Lignans; Linear Models; Male; Mice, Inbred BALB C; Phenyl Ethers; Respiratory Function Tests; Respiratory Hypersensitivity | 2020 |
Magnolol ameliorates the accumulation of reactive oxidative stress and inflammation in diabetic periodontitis.
Topics: Biphenyl Compounds; Diabetes Mellitus; Glycation End Products, Advanced; Humans; Inflammation; Lignans; Oxidative Stress; Periodontitis; Reactive Oxygen Species | 2021 |
Magnolol attenuates the inflammation and apoptosis through the activation of SIRT1 in experimental stroke rats.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Biphenyl Compounds; Gene Expression Regulation; Hypoxia, Brain; Inflammation; Lignans; Nerve Tissue Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Sirtuin 1; Stroke | 2017 |
Synthesis, Characterization, and Biological Evaluations of 1,3,5-Triazine Derivatives of Metformin Cyclization with Berberine and Magnolol in the Presence of Sodium Methylate.
Topics: Anti-Inflammatory Agents; Berberine; Biphenyl Compounds; Cyclization; Humans; Inflammation; Insulin Resistance; Lignans; Metformin; Molecular Structure; Sodium; Structure-Activity Relationship; Triazines | 2017 |
Magnolol treatment attenuates dextran sulphate sodium-induced murine experimental colitis by regulating inflammation and mucosal damage.
Topics: Animals; Biphenyl Compounds; Cecum; Colitis, Ulcerative; Colon; Cytokines; Dextran Sulfate; Gastrointestinal Agents; Inflammation; Inflammation Mediators; Intestinal Mucosa; Lignans; Male; Mice; Mice, Inbred C57BL; Occludin; PPAR gamma; Weight Loss | 2018 |
Magnolol attenuates the inflammation and enhances phagocytosis through the activation of MAPK, NF-κB signal pathways in vitro and in vivo.
Topics: Animals; Biphenyl Compounds; Cytokines; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Inflammation; Lignans; MAP Kinase Signaling System; Mice; NF-kappa B; Phagocytosis; U937 Cells | 2019 |
Magnolol exhibits anti-inflammatory and neuroprotective effects in a rat model of intracerebral haemorrhage.
Topics: Animals; Anti-Inflammatory Agents; Astrocytes; Biphenyl Compounds; Blood-Brain Barrier; Brain; Brain Edema; Brain Ischemia; Cerebral Hemorrhage; Cytokines; Disease Models, Animal; Inflammation; Lignans; Male; Neuroglia; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Stroke | 2019 |
Magnolol inhibits LPS-induced inflammatory response in uterine epithelial cells : magnolol inhibits LPS-induced inflammatory response.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biphenyl Compounds; Cell Survival; Cells, Cultured; Down-Regulation; Endometritis; Enzyme Activation; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Female; I-kappa B Proteins; Inflammation; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Lignans; Lipopolysaccharides; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; NF-kappa B; NF-KappaB Inhibitor alpha; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; Uterus | 2013 |
Long-term supplementation of honokiol and magnolol ameliorates body fat accumulation, insulin resistance, and adipose inflammation in high-fat fed mice.
Topics: Adipogenesis; Adiponectin; Adipose Tissue, White; Adiposity; Animals; Biphenyl Compounds; Blood Glucose; Body Weight; Chemokine CCL2; Cholesterol; Diet, High-Fat; Dietary Supplements; Energy Metabolism; Glucose Tolerance Test; Inflammation; Insulin Resistance; Interleukin-10; Interleukin-6; Lignans; Liver; Male; Mice; Mice, Inbred C57BL; Triglycerides; Tumor Necrosis Factor-alpha | 2013 |
Magnolol inhibits the inflammatory response in mouse mammary epithelial cells and a mouse mastitis model.
Topics: Animals; Biphenyl Compounds; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Epithelial Cells; Female; Humans; Inflammation; Lignans; Male; Mammary Glands, Animal; Mastitis; Mice; Mice, Inbred BALB C | 2015 |
Potential use of Magnolia officinalis bark polyphenols in the treatment of cannabis dependence.
Topics: Animals; Biphenyl Compounds; Cannabis; Humans; Inflammation; Lignans; Magnolia; Marijuana Abuse; Plant Bark; Plant Extracts; Polyphenols; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, G-Protein-Coupled | 2014 |
Pharmacokinetics and pharmacodynamics of Da-Cheng-Qi decoction in the liver of rats with severe acute pancreatitis.
Topics: Acute Disease; Alanine Transaminase; Animals; Anthraquinones; Aspartate Aminotransferases; Biphenyl Compounds; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Emodin; Flavanones; Hesperidin; Inflammation; Lignans; Liver; Male; Pancreatitis; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry | 2017 |
Antinociceptive actions of honokiol and magnolol on glutamatergic and inflammatory pain.
Topics: Analgesics; Animals; Anti-Infective Agents; Biphenyl Compounds; Dinoprostone; Excitatory Amino Acid Agents; Glycine; Immunohistochemistry; Inflammation; Lignans; Male; Mice; N-Methylaspartate; Phenylacetates; Proto-Oncogene Proteins c-fos; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate | 2009 |
Cardiovascular protection of magnolol: cell-type specificity and dose-related effects.
Topics: Apoptosis; Biphenyl Compounds; Cardiovascular System; Drugs, Chinese Herbal; Humans; Inflammation; Lignans; Magnolia; Muscle, Smooth, Vascular; Myocytes, Cardiac; Myocytes, Smooth Muscle | 2012 |
Magnolol inhibits lipopolysaccharide-induced inflammatory response by interfering with TLR4 mediated NF-κB and MAPKs signaling pathways.
Topics: Animals; Anti-Inflammatory Agents; Biphenyl Compounds; Cell Survival; Cells, Cultured; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; HEK293 Cells; Humans; Inflammation; Interleukin-8; Lignans; Lipopolysaccharides; MAP Kinase Signaling System; Mice; NF-kappa B; Signal Transduction; Toll-Like Receptor 4; Transfection | 2013 |
Effects of honokiol and magnolol on acute and inflammatory pain models in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biphenyl Compounds; Central Nervous System Depressants; Disease Models, Animal; Drug Evaluation, Preclinical; Fixatives; Formaldehyde; Inflammation; Lignans; Lumbosacral Region; Magnolia; Memory; Mice; Pain; Posterior Horn Cells; Proto-Oncogene Proteins c-fos | 2007 |
The inhibitory effect of magnolol on cutaneous permeability in mice is probably mediated by a nonselective vascular hyporeactivity to mediators.
Topics: Adrenalectomy; Animals; Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Capillary Permeability; Edema; Electric Stimulation; Exudates and Transudates; Histamine; Inflammation; Lignans; Mast Cells; Mice; Mice, Inbred ICR; Neurons, Afferent; p-Methoxy-N-methylphenethylamine; Passive Cutaneous Anaphylaxis; Regional Blood Flow; Serotonin Antagonists; Skin; Skin Absorption | 1993 |